Pharmagen, Inc. Stock

Equities

Market Closed - OTC Markets Other stock markets 09:45:38 2024-06-25 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Duration

Period

Style

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	15-11-29	CI
Pharmagen, Inc. Announces Management Changes	14-07-02	CI
Pharmagen, Inc. Announces Executive Changes	14-06-11	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	14-06-11	CI
Pharmagen Appoints Additional Members to its Board of Directors	14-05-29	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	14-05-06	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	14-04-29	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	14-03-31	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	14-02-24	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	14-02-24	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	13-12-17	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	13-12-11	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	13-11-14	CI
Pharmagen Seeks Acquisitions	13-10-31	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	13-08-09	CI